|
THE FEMALE HEALTH COMPANY REPORTS:
Purchase of Shares by Director
The Female Health Company Reported that Stephen M. Dearholt, a director, has purchased 208,863 shares of common stock during the last 30 days. Mr. Dearholt's aggregate beneficial ownership now totals 2,705,583 shares of the Company's common stock or 20.29%.
The
Female Health Company, based in Chicago, owns certain worldwide rights to
The Female Condomä
including patents that have been issued in the United States, United
Kingdom, Japan, France, Italy, Germany, Spain, The People’s Republic of
China, Canada, New Zealand, South Korea and Australia.
The Female Condomä
is the only available product controlled by a woman that protects against
sexually transmitted diseases including HIV/AIDS, and unintended
pregnancy. “Safe Harbor” Statement under
the Private Securities Litigation Reform Action of 1995:
The statements in this release which are not historical fact are
forward-looking statements based upon the Company’s current plans and
strategies, and reflect the Company’s current assessment of the risks
and uncertainties related to its business, including such things as
product demand and market acceptance; the economic and business
environment and the impact of governmental regulations, both in the United
States and abroad; the effects of competitive products and pricing
pressures; currency risks; capacity; efficiency and supply constraints;
and other risks detailed in the Company’s press releases, shareholder
communication and Securities and Exchange Commission filings.
Actual events affecting the
Company and the impact of such events on the Company’s operations may
vary from those currently anticipated. For more information about the Female Health
Company, dial toll-free via fax,
|